SARS-CoV-2 Antigen Rapid Test
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
The Flowflex™ SARS-CoV-2 Antigen Rapid Test (Nasal/Nasopharyngeal/Saliva) is a lateral flow chromatographic immunoassay for the qualitative detection the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab, nasopharyngeal swab and saliva swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms. The SARS-CoV-2 Antigen Rapid Test (Nasal/Nasopharyngeal/Saliva) can also test specimens from asymptomatic individuals.
Nasal swab, nasopharyngeal swab and saliva swab specimens
Results at 15 minutes
Excellent performance compared to molecular methods
Room temperature storage
|
Nasal Swab Specimens |
|
|
Sensitivity |
97.1% |
|
Specificity |
99.5% |
|
Accuracy |
98.8% |
|
Nasopharyngeal Swab Specimens |
|
|
Sensitivity |
97.6% |
|
Specificity |
99.4% |
|
Accuracy |
98.7% |
|
Saliva Swab Specimens |
|
|
Sensitivity |
90.7% |
|
Specificity |
99.9% |
|
Accuracy |
97.2% |
*95% Confidence Intervals
|
Product Name |
Catalog No. |
Format |
Specimen |
Package |
|
Flowflex™ SARS-CoV-2 Antigen Rapid Test (Nasal/Nasopharyngeal/Saliva) |
L031-129G5 |
Cassette |
Nasal swab, nasopharyngeal swab and saliva swab |
20 Test/Kit |
|
L031-129H5 |
Cassette |
Nasal swab, nasopharyngeal swab and saliva swab |
25 Tests/Kit |
